U.S. backs waiving patent protections for COVID vaccines, citing global health crisis

The Biden administration announced Wednesday that it supports waiving intellectual property protections for Covid-19 vaccines. Such a waiver could remove obstacles to ramping up the production of vaccines in developing countries. The move comes as coronavirus infections surge to their highest levels in countries that have struggled to procure or distribute vaccines.